Next, from both CNS+ and CNS− patient groups, a representative pB-ALL and a representative T-ALL CSF sample processed by ultracentrifugation (nonselective for cluster of differentiation markers) were supervised by immunolabelling for CD63 and CD81 markers using transmission electron microscopy (TEM). The gene discussed is CD63; the disease is acute lymphoblastic leukemia.